| |
| |
|
| Insider
Information: |
Crooke Stanley T |
| Relationship: |
Director, 10% Owner |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,021 |
|
|
Indirect Shares
|
7,547,002 |
|
|
| Direct
Value |
$78,718 |
|
|
|
Indirect Value
|
$35,098,088 |
|
|
| Total
Shares |
7,549,023 |
|
|
| Total
Value |
$35,176,806 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Exec Chairman of the B... |
2021-01-26 |
2,021 |
2021-01-26 |
497,502 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director, 10% Owner |
2012-10-10 |
0 |
2012-10-10 |
7,049,500 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
463 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 15 of 19
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-04-19 |
4 |
OE |
$7.25 |
$3,625 |
I/I |
500 |
3,562 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-04-19 |
4 |
AS |
$43.25 |
$21,625 |
I/I |
(500) |
3,062 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-04-25 |
4 |
AS |
$47.81 |
$71,715 |
I/I |
(1,500) |
3,062 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-04-25 |
4 |
OE |
$7.25 |
$10,875 |
I/I |
1,500 |
4,562 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-04-25 |
4 |
AS |
$47.81 |
$717,150 |
D/D |
(15,000) |
38,014 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-04-25 |
4 |
OE |
$7.25 |
$108,750 |
D/D |
15,000 |
53,014 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-07-03 |
4 |
OE |
$7.25 |
$120,193 |
D/D |
15,000 |
39,552 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-07-03 |
4 |
AS |
$52.08 |
$781,538 |
D/D |
(15,000) |
38,014 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-07-03 |
4 |
OE |
$7.25 |
$10,875 |
I/I |
1,500 |
4,562 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-07-03 |
4 |
AS |
$52.10 |
$78,150 |
I/I |
(1,500) |
3,062 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-07-17 |
4 |
AS |
$52.45 |
$78,675 |
I/I |
(1,500) |
3,062 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-07-17 |
4 |
OE |
$7.25 |
$10,875 |
I/I |
1,500 |
4,562 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-07-17 |
4 |
AS |
$52.45 |
$786,750 |
D/D |
(15,000) |
38,014 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-07-17 |
4 |
OE |
$14.69 |
$220,350 |
D/D |
15,000 |
53,014 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-07-20 |
4 |
OE |
$14.69 |
$146,900 |
D/D |
10,000 |
48,014 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-07-20 |
4 |
AS |
$55.35 |
$553,500 |
D/D |
(10,000) |
38,014 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-07-20 |
4 |
OE |
$7.25 |
$7,250 |
I/I |
1,000 |
4,062 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-07-20 |
4 |
AS |
$55.35 |
$55,350 |
I/I |
(1,000) |
3,062 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-10-02 |
4 |
AS |
$51.45 |
$78,000 |
I/I |
(1,500) |
3,062 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-10-02 |
4 |
OE |
$7.25 |
$10,875 |
I/I |
1,500 |
3,562 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-10-02 |
4 |
AS |
$51.45 |
$780,000 |
D/D |
(15,000) |
38,014 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-10-02 |
4 |
OE |
$14.69 |
$220,350 |
D/D |
15,000 |
43,014 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-10-04 |
4 |
OE |
$14.69 |
$146,900 |
D/D |
10,000 |
43,014 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-10-04 |
4 |
AS |
$54.20 |
$542,250 |
D/D |
(10,000) |
38,014 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chairman and CEO |
• • – |
2017-10-04 |
4 |
OE |
$7.25 |
$7,250 |
I/I |
1,000 |
3,562 |
0 |
- |
|
463 Records found
|
|
Page 15 of 19 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
